Side-effect deep dive
Fatigue + low energy on GLP-1 medications
Common in early titration from reduced calorie + carb intake. Persistent fatigue past week 8 warrants thyroid, ferritin, B12 labs.
Why it happens
Rapid drop in calorie + carbohydrate intake during titration produces a transient low-energy state similar to mild starvation. Most patients adapt by week 6-8 at stable dose. Persistent fatigue past that window suggests nutritional deficiency or thyroid issue rather than GLP-1.
How to manage it
- 1.Adequate protein intake (1.2-1.6 g/kg ideal body weight)
- 2.Iron-rich foods or supplement if labs show low ferritin
- 3.Hydration β₯80 oz/day (mild dehydration mimics fatigue)
- 4.Avoid aggressive calorie deficits β eat at least 1,200-1,400 cal/day
- 5.Get B12 + thyroid panel if fatigue persists past week 8
When to call your prescriber
- Persistent severe fatigue past week 8 at stable dose
- Fatigue with depression symptoms
- Orthostatic dizziness (rapid weight loss + dehydration)
Affected medications
Sources
People also ask
Common questions readers ask
- Does Ozempic cause hair loss?
- Not directly. Hair shedding (telogen effluvium) is reported by some patients ~3 months into rapid weight loss β typical of any rapid-weight-loss state, not unique to GLP-1. Full evidence-graded answer
- What foods should you avoid on a GLP-1?
- Avoid greasy, fried, and ultra-processed foods (worst nausea), high-sugar drinks (rapid reflux), and large portions of red meat or cruciferous vegetables (slow gastric emptying compounds GI side effects). Adequate protein + soluble fiber + hydration are the wins. Full evidence-graded answer
- How long do GLP-1 side effects last?
- Most GI side effects (nausea, constipation, reflux) peak in weeks 1-2 after each dose increase and resolve within 4 weeks. If you stay on a stable dose without further titration, side effects typically fade for β₯80% of patients by week 12. Full evidence-graded answer
- Does Ozempic cause stomach paralysis (gastroparesis)?
- GLP-1 medications delay gastric emptying as part of their mechanism β that is not stomach paralysis. True gastroparesis after GLP-1 use is rare and the absolute risk in pharmacovigilance data is small. Symptoms (severe nausea, vomiting, abdominal pain past week 8) warrant evaluation. Full evidence-graded answer
Editorial information based on FDA-label prevalence data + AERS pharmacovigilance + patient-reported outcome corpora. Not personal medical advice.